Corpay vs RB Global
CPAY and RBA side by side, both in miscellaneous business services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CPAY and RBA compare
Corpay is the larger company, worth 1.7 times as much as RB Global ($30.3B against $17.7B).
On earnings, Corpay is cheaper: it trades at 25.4× trailing earnings, against 40.9× for RB Global.
Corpay grew revenue faster over the last twelve months (21.2% versus 9.7% for RB Global).
Corpay keeps more of each dollar of sales as profit, with a net margin of 23.7% compared with 10.0% at RB Global.
RB Global pays a dividend yielding 0.67%; Corpay does not pay one.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CPAY | RBA |
|---|---|---|
| Size and price | ||
| Market cap | $30.3B | $17.7B |
| Share price | $461.73 | $95.32 |
| Change, 1 year | 63.1% | −5.3% |
| Change, 5 years | 115% | 37.9% |
| Beta (5Y) | 1.09 | 0.03 |
| Employees | 12K | 8,000 |
| StockData Score | ||
| Total score | 11 | 11 |
| Valuation score | 1 | 2 (better) |
| Growth score | 3 (better) | 2 |
| Performance score | 5 (better) | 3 |
| Health score | 2 | 3 (better) |
| Dividend score | 0 | 1 (better) |
| Valuation | ||
| P/E | 25.4× (better) | 40.9× |
| P/S | 5.8× | 3.6× (better) |
| P/B | 9.2× | 3.2× (better) |
| EV/EBITDA | 11.8× (better) | 15.6× |
| P/FCF | 22.7× (better) | 28.9× |
| PEG | 3.87 | – |
| FCF yield | 4.4% (better) | 3.5% |
| Fair value | $431.88 | $87.77 |
| Margin of safety | −6.9% (better) | −8.6% |
| Growth | ||
| Revenue growth (TTM) | 21.2% (better) | 9.7% |
| Revenue growth, 5Y average | 13.6% | 27.2% (better) |
| Net income growth (TTM) | 18.1% (better) | 15.9% |
| EPS growth (TTM) | 23.4% (better) | 15.3% |
| EPS growth, 5Y average | 13.1% (better) | 5.8% |
| Profitability | ||
| Operating margin | 43.9% (better) | 16.0% |
| Net margin | 23.7% (better) | 10.0% |
| FCF margin | 25.5% (better) | 12.6% |
| Return on equity | 33.7% (better) | 8.8% |
| Return on invested capital | 33.7% (better) | 8.2% |
| Financial health | ||
| Debt / equity | 1.57 | 0.52 (better) |
| Net debt / EBITDA | 0.76 (better) | 1.85 |
| Interest coverage | 5.1× (better) | 4.3× |
| Current ratio | 0.95 | 1.31 (better) |
| Altman Z-score | 1.72 | 2.44 (better) |
| Piotroski F-score | 5 | 6 (better) |
| Dividends and buybacks | ||
| Dividend yield | – | 0.67% |
| Buyback yield | 7.0% | – |
| Shareholder yield | 7.0% (better) | 0.67% |
| Ownership | ||
| Held by institutions | 97.8% | 98.3% |
| Held by insiders | 5.3% | 0.26% |
| Insider net buying, 12 months | −$146M | −$2.2M (better) |
| Superinvestors holding | 1 | – |
| Short interest, % of float | 5.8% | 9.9% |
Go deeper
- CPAY stock overview
- CPAY income statement
- CPAY valuation and score
- RBA stock overview
- RBA income statement
- RBA valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.